Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,891.00
Bid: 1,887.00
Ask: 1,889.00
Change: 16.00 (0.85%)
Spread: 2.00 (0.106%)
Open: 1,897.00
High: 1,897.00
Low: 1,877.00
Prev. Close: 1,875.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Tue, 10th Mar 2015 15:56

UK Earnings, Trading Statements Calendar 
Wednesday, March 11 
Centaur MediaFull Year Results
N BrownTrading Statement
BWINFull Year Results
FoxtonsFull Year Results
Brooks MacdonaldHalf Year Results
FerrexpoFull Year Results
HikmaFull Year Results
Servelec GroupFull Year Results
Modern WaterFull Year Results
Michael Page InternationalFull Year Results
Ceres Power Holdings Half Year Results
FDM GroupFull Year Results
Boohoo.comTrading Statement
Thursday, March 12 
Cineworld GroupFull Year Results
LSL PropertyFull Year Results
Wm Morrison SupermarketsFull Year Results
ComputacenterTrading Statement
FennerTrading Statement
Home Retail GroupTrading Statement
SIGFull Year Results
TT ElectronicsFull Year Results
ASOSTrading Statement
Stock Spirits GroupFull Year Results
Cambridge Cognition HoldingsFull Year Results
SOCO InternationalFull Year Results
Secure Income REITFull Year Results 
Friday, March 13 
JD WetherspoonHalf Year Results
SthreeQ1 Interim Management Statement
Oxford BiomedicaFull Year Results
Independent News & MediaFull Year Results 
Monday, March 16 
Tribal GroupFull Year Results
Real Estate Investors Full Year Results
EKF Diagnostics HoldingsFull Year Results
BradyFull Year Results
Smart Metering SystemsFull Year Results
Petards GroupFull Year Results
Tuesday, March 17 
French Connection GroupFull Year Results
RegenersisHalf Year Results
AntofagastaFull Year Results
Mears GroupFull Year Results
IG GroupInterim Management Statement 
Fairpoint GroupFull Year Results
J SainsburyQ4 Trading Statement
WANdiscoFull Year Results
Just EatFull Year Results
SafeCharge International GroupFull Year Results
Onesavings BankFull Year Results
GfinityHalf Year Results
Good Energy GroupFull Year Results
KBC Advanced Technologies Full Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.
  

More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.